|
Atomistry » Fluorine » PDB 7bj6-7ckn » 7bjo | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 7bj6-7ckn » 7bjo » |
Fluorine in PDB 7bjo: Crystal Structure of CHK1-10PT-Mutant Complex with Compound 13Enzymatic activity of Crystal Structure of CHK1-10PT-Mutant Complex with Compound 13
All present enzymatic activity of Crystal Structure of CHK1-10PT-Mutant Complex with Compound 13:
2.7.11.1; Protein crystallography data
The structure of Crystal Structure of CHK1-10PT-Mutant Complex with Compound 13, PDB code: 7bjo
was solved by
P.Dokurno,
A.E.Surgenor,
D.S.Williamson,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of CHK1-10PT-Mutant Complex with Compound 13
(pdb code 7bjo). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Crystal Structure of CHK1-10PT-Mutant Complex with Compound 13, PDB code: 7bjo: Jump to Fluorine binding site number: 1; 2; Fluorine binding site 1 out of 2 in 7bjoGo back to Fluorine Binding Sites List in 7bjo
Fluorine binding site 1 out
of 2 in the Crystal Structure of CHK1-10PT-Mutant Complex with Compound 13
Mono view Stereo pair view
Fluorine binding site 2 out of 2 in 7bjoGo back to Fluorine Binding Sites List in 7bjo
Fluorine binding site 2 out
of 2 in the Crystal Structure of CHK1-10PT-Mutant Complex with Compound 13
Mono view Stereo pair view
Reference:
D.S.Williamson,
G.P.Smith,
G.K.Mikkelsen,
T.Jensen,
P.Acheson-Dossang,
L.Badolo,
S.T.Bedford,
V.Chell,
I.J.Chen,
P.Dokurno,
M.Hentzer,
S.Newland,
S.C.Ray,
T.Shaw,
A.E.Surgenor,
L.Terry,
Y.Wang,
K.V.Christensen.
Design and Synthesis of Pyrrolo[2,3- D ]Pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using A Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate. J.Med.Chem. 2021.
Page generated: Fri Aug 2 06:02:01 2024
ISSN: ISSN 0022-2623 PubMed: 34184879 DOI: 10.1021/ACS.JMEDCHEM.1C00720 |
Last articlesZn in 9JYWZn in 9IR4 Zn in 9IR3 Zn in 9GMX Zn in 9GMW Zn in 9JEJ Zn in 9ERF Zn in 9ERE Zn in 9EGV Zn in 9EGW |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |